Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 54.16M
March 31, 2026 51.62M
December 31, 2025 50.89M
September 30, 2025 50.62M
June 30, 2025 50.39M
March 31, 2025 50.12M
December 31, 2024 49.55M
September 30, 2024 49.53M
June 30, 2024 49.32M
March 31, 2024 49.04M
December 31, 2023 44.05M
September 30, 2023 43.99M
June 30, 2023 43.62M
March 31, 2023 43.46M
December 31, 2022 43.30M
September 30, 2022 43.29M
June 30, 2022 43.17M
March 31, 2022 42.98M
December 31, 2021 42.83M
September 30, 2021 42.75M
June 30, 2021 42.56M
March 31, 2021 42.50M
December 31, 2020 37.48M
Date Value
September 30, 2020 37.40M
June 30, 2020 37.29M
March 31, 2020 37.19M
December 31, 2019 36.99M
September 30, 2019 36.84M
June 30, 2019 36.75M
March 31, 2019 36.61M
December 31, 2018 36.12M
September 30, 2018 35.70M
June 30, 2018 32.28M
March 31, 2018 31.90M
December 31, 2017 31.30M
September 30, 2017 31.11M
June 30, 2017 30.85M
March 31, 2017 30.24M
December 31, 2016 26.48M
September 30, 2016 26.48M
June 30, 2016 26.46M
March 31, 2016 26.34M
December 31, 2015 26.31M
September 30, 2015 26.31M
June 30, 2015 25.44M
March 31, 2015 26.30M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. 1.767B
Capricor Therapeutics, Inc. 58.11M
Biogen, Inc. 147.70M
United Therapeutics Corp. 42.68M
Ardelyx, Inc. 249.15M